On July 22, Shanghai Kam Nanyang Medical Devices Co., Ltd. disclosed a major asset restructuring report.
At this point, Camer Medical has finally made new progress in the multinational restructuring that has been planned for half a year.
60 million yuan to acquire a Korean company
On July 22, Kam Medical issued “Shanghai Kam Nanyang Medical Devices Co., Ltd. Payment of Cash Purchase Assets and Major Assets Restructuring Reportâ€, saying that the wholly-owned subsidiary of Bailin Industrial and the Korean company GEMSS and its shareholder Lee Ja Seong and Lee Sun Joo signed the "New Share Subscription Contract", which will pay 60 million yuan to subscribe for 14.34 million shares of GEMSS, accounting for 75% of its total issued share capital.
Upon completion of this transaction, GEMSS will become the holding company of Cam Medical.
It is understood that the evaluation value of GEMSS is significantly higher than its book value. As of the evaluation of the benchmark date on November 30, 2015, GEMSS's existing 100% equity evaluation value totaled 25.13 million yuan, and the audited net asset book value was -848.643 million yuan, an increase of 110 million yuan.
The announcement shows that GEMSS has an experienced technical team and a good reputation for market brands and services, and has a sales network overseas, which has a good market prospect and is expected to have good profitability.
Regarding the source of funds for this transaction, Camm Medical clearly stated in the announcement that 30 million yuan was from the company's own funds, 30 million yuan was obtained through bank loans, totaling 60 million yuan, and finally paid by Camer Medical through paid-in The way is injected into the industry.
Organic Tapioca Resistant Dextrin Syrup
Resistant Dextrin Prebiotic, Organic Soluble Dextrin,High Ingredient Tapioca Fiber,Low Calorie Soluble Fiber
Shandong Bailong Chuangyuan Bio-tech Co.,Ltd. Qingdao Branch , https://www.sdblcycn.com